Core Viewpoint - CDT Equity Inc. has approved a cryptocurrency-based treasury reserve strategy to diversify its capital management approach and enhance its innovation-led model [1][2] Group 1: Treasury Reserve Strategy - The strategy aims to hold part of the current balance sheet in digital assets, reflecting the company's belief in the long-term strategic and financial benefits of exposure to cryptocurrencies [2] - The decision is influenced by significant market activity from investors in the cryptocurrency and stablecoin sector, positioning the company for potentially transformative transactions [2] Group 2: Technological Development - CDT is collaborating with Sarborg to create an autonomous AI-led system for evaluating the cryptocurrency market, which will provide real-time analytics and automated execution systems [3] - The company is also focused on advancing its pipeline of Phase-2 ready pharmaceutical assets, leveraging algorithmic repurposing and IP-led licensing opportunities [3] Group 3: Share Information - As of September 2, 2025, CDT has 3,382,025 shares of common stock outstanding, with a total of 250,000,000 authorized shares [4] - The company continues to utilize its at-the-market (ATM) facility with A.G.P./Alliance Global Partners as its primary funding source [4]

Core Viewpoint - The company is rebranding to Hyperion DeFi, Inc. and will begin trading under the ticker symbol "HYPD" on Nasdaq effective July 3, 2025, reflecting its focus on a cryptocurrency treasury reserve strategy centered around the HYPE token [2][3][4]. Company Overview - Hyperion DeFi, Inc. is the first publicly listed U.S. company to build a strategic treasury of HYPE, the native token of the Hyperliquid protocol [2][6]. - The company aims to provide shareholders with simplified access to the Hyperliquid ecosystem, which is recognized as one of the fastest-growing and highest revenue-generating blockchains globally [6]. Strategic Initiatives - The name change signifies a new vision for the company, emphasizing its potential to become the largest holder of the HYPE token and a leader in cryptocurrency-based treasury assets [4]. - The company has launched the Kinetiq x Hyperion validator, which is now live, and has begun staking its HYPE holdings to generate yield [4][6]. Product Development - Hyperion DeFi is also developing the Optejet User Filled Device (UFD), designed for various topical ophthalmic liquids, which aims to improve treatment compliance and outcomes for patients with chronic eye diseases [7].